News

Telix Pharmaceuticals Limited: Telix's Illuccix PSMA-PET Imaging Agent Approved in the Czech Republic
New approval provides hospitals and clinics in the Czech Republic with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, May 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...
Telix's Illuccix® PSMA-PET Imaging Agent Approved in the Czech Republic
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...